Recent Updates
Recently added Catalysts
RMD Positive Sentiment Score: 70/100

ResMed to Report Fourth Quarter Fiscal 2023 Earnings on August 3, 2023

Key Takeaway: ResMed has announced it will release its fourth quarter fiscal 2023 earnings on August 3, 2023. The financial and operational results will be disclosed after the New York Stock Exchange closes, followed by a management-hosted webcast to discuss the outcomes. The earnings call will be accessible only through the provided webcast link, and a replay will be available shortly after the event. This release is part of ResMed's commitment to transparency and ongoing improvement in healthcare technology solutions.

Market Sentiment Analysis

POSITIVE FACTORS

  • Upcoming earnings report indicates transparency and accountability.
  • Webcast allows investors to gain insights directly from management.
  • Continued innovation in digital health technologies showcased.

Full Press Release Details

SAN DIEGO, July 06, 2023 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the fourth quarter of fiscal year 2023 on Thursday, August 3, 2023, after the New York Stock Exchange closes. Following the release, ResMed management will host a webcast to discuss the results. Other forward-looking and material information may also be discussed during the webcast.
Earnings webcast details:
Location: http://investor.resmed.com
Date: Thursday, August 3, 2023
Time: 1:30 p.m. PDT / 4:30 p.m. EDT
International: London, Thursday, August 3, 2023, 9:30 p.m. BST
Sydney, Friday, August 4, 2023, 6:30 a.m. AEST
Please note, ResMed does not use outside phone lines to access the earnings call, the call is accessible via the above webcast link only.
A replay of the earnings webcast will be accessible on ResMed’s website and available approximately two hours after the webcast. In addition, a phone replay will be available approximately three hours after the webcast and will be accessible from August 3, 2023, until August 17, 2023, at:
U.S.: +1 877.660.6853
International: +1 201.612.7415
Conference ID: 13739812
At ResMed (NYSE: RMD, ASX: RMD) we pioneer innovative solutions that treat and keep people out of the hospital, empowering them to live healthier, higher-quality lives. Our digital health technologies and cloud-connected medical devices transform care for people with sleep apnea, COPD, and other chronic diseases. Our comprehensive out-of-hospital software platforms support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. By enabling better care, we improve quality of life, reduce the impact of chronic disease, and lower costs for consumers and healthcare systems in more than 140 countries. To learn more, visit ResMed.com and follow @ResMed.
For investors For media
Amy Wakeham Jayme Rubenstein
+1 858.836.5000 +1 508.769.8440
investorrelations@resmed.com news@resmed.com

Frequently Asked Questions

When will ResMed release its Q4 2023 results?

ResMed will announce its Q4 2023 results on August 3, 2023.

What time is the ResMed earnings webcast?

The earnings webcast is at 1:30 p.m. PDT on August 3, 2023.

How can I access the ResMed earnings call?

The earnings call can be accessed via the webcast link only.

Will there be a replay of the earnings webcast?

Yes, a replay will be available on ResMed's website two hours post-webcast.

What is ResMed's focus in healthcare?

ResMed focuses on innovative solutions for chronic disease management.

Last updated: Jul 6, 2023